Optimization of phage-immobilized ELISA for autoantibody profiling in human sera

Cited 5 time in scopus
Metadata Downloads
Title
Optimization of phage-immobilized ELISA for autoantibody profiling in human sera
Author(s)
Mi-Kyung Woo; Chang Gyu Heo; Hai Min Hwang; Jeong Heon Ko; Hyang Sook Yoo; Eun Wie Cho
Bibliographic Citation
Biotechnology Letters, vol. 33, no. 4, pp. 655-661
Publication Year
2011
Abstract
Phage libraries displaying cDNA or random peptides have been used for profiling autoantibodies in cancer. The detection of autoantibodies in human sera using phages displaying specific epitopes is usually performed by phage-immobilized ELISAs which can detect specific antibodies without identification of whole antigens. However, these ELISAs can give feeble detection signals that are indistinguishable from background signals which are caused by human sera. To improve the usefulness of phage ELISA for human sera, the conditions for each step in phage ELISA were optimized. The antigenicity of phage antigens was maximal when using coating buffer of neutral pH. By using protein-free blocking buffer and pre-adsorbing human sera with phage host cell ER2738 extracts significantly decreased non-specific signals. Finally, when these conditions were applied to phage ELISA using K10P1, the values of the negative controls were concentrated near cutoff values, which made the assay more reliable. The optimized phage ELISA conditions described here would increase the efficacy of detection specific autoantibodies in human sera.
Keyword
Blocking bufferCoating bufferHuman serumPhage ELISAPre-adsorption
ISSN
0141-5492
Publisher
Springer
DOI
http://dx.doi.org/10.1007/s10529-010-0483-6
Type
Article
Appears in Collections:
Synthetic Biology and Bioengineering Research Institute > Genome Editing Research Center > 1. Journal Articles
Division of Biomedical Research > Rare Disease Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.